Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

The Lancet

Volumn 340, Issue 8823, 1992, Pages 818-819

  Roberts Jr , J D ^a   Polaner, D M ^a   Zapol, W M ^a   Lang, P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; DOPAMINE; NARCOTIC AGENT; NITRIC OXIDE;

ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; HUMAN; HYPOXEMIA; INHALATIONAL DRUG ADMINISTRATION; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADMINISTRATION, INHALATION; ANOXEMIA; BLOOD PRESSURE; HUMAN; INFANT, NEWBORN; METHEMOGLOBIN; NITRIC OXIDE; OXIMETRY; OXYGEN; PARTIAL PRESSURE; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATION, ARTIFICIAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026731804     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)92686-A     Document Type: Article

References (8)

1. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
2. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
3. Vascular endothelial cells synthesize nitric oxide from L-argmine
4. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase
5. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
6. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
7. Inhaled nitric oxide is a selective pulmonary vasodilator of the hypoxic newborn lamb
8. Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia